Drug treatment of Alzheimer's disease and responders to rivastigmine beyond 12 weeks
- PMID: 10607978
- DOI: 10.1002/(sici)1099-1166(199912)14:12<1078::aid-gps73>3.0.co;2-s
Drug treatment of Alzheimer's disease and responders to rivastigmine beyond 12 weeks
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
